What oral antibiotic is recommended for a superficial burn with signs of infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oral Antibiotics for Superficial Burn Infections

For superficial burn wounds with signs of infection, dicloxacillin or cephalexin should be used as first-line oral antibiotic therapy, with clindamycin as an alternative for penicillin-allergic patients. 1, 2

First-Line Treatment Options

  • Dicloxacillin (500 mg orally four times daily) for 7-10 days is recommended as a first-line treatment for superficial burn infections 1, 2
  • Cephalexin (500 mg orally three times daily) for 7-10 days is an equally effective first-line option 1, 2
  • These antibiotics target Gram-positive bacteria, particularly Staphylococcus aureus and streptococci, which are the most common pathogens in early burn wound infections 3, 1

Alternative Options for Penicillin Allergy or MRSA Concerns

  • Clindamycin (300-450 mg orally three times daily) for 7-10 days is the preferred alternative for penicillin-allergic patients 2, 4
  • Trimethoprim-sulfamethoxazole (1-2 DS tablets twice daily) should be considered when MRSA is suspected 1, 2
  • Doxycycline (100 mg orally twice daily) is another effective option for MRSA coverage 2

Treatment Approach Based on Infection Severity

  • For mild to moderate infections in patients without recent antibiotic exposure, therapy targeting only aerobic Gram-positive cocci is sufficient 3, 1
  • Burn wound infections are often polymicrobial, initially with Gram-positive bacteria from the patient's skin flora, but can become colonized with Gram-negative bacteria within a week 3
  • Consider empiric therapy for community-acquired MRSA for patients at risk or who don't respond to first-line therapy 1

Duration of Treatment

  • For mild superficial infections, antibiotic therapy should typically last 7-10 days 1, 2
  • Continue antibiotics until resolution of infection signs but not through complete wound healing 3
  • Reassess the wound within 48-72 hours to evaluate treatment response 1

Wound Care Considerations

  • Proper wound cleansing and debridement of necrotic tissue are crucial adjuncts to antibiotic therapy 3, 1
  • Topical antimicrobial agents may be used alongside oral antibiotics for superficial burns with signs of infection 5, 6
  • Silver sulfadiazine remains the most frequently used topical prophylactic agent for burn wounds, though it may delay healing if used long-term on superficial burns 3, 7

Special Considerations

  • Bacterial cultures should guide definitive antibiotic selection when available 3
  • Systemic antibiotic prophylaxis is not recommended for uninfected burn wounds 3
  • Switch to broader-spectrum antibiotics if there's no improvement after 48 hours of treatment 1
  • Consider parenteral therapy for moderate to severe infections, at least initially 3, 1

When to Consider Referral

  • Deep burns or those involving >10% total body surface area 5
  • Signs of systemic infection or sepsis 3
  • Failure to respond to appropriate oral antibiotic therapy 1
  • Burns in high-risk locations (face, hands, feet, genitals, major joints) 3

References

Guideline

Treatment of Superficial Wound Skin Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Elbow Bursitis with Erythema

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Outpatient burns: prevention and care.

American family physician, 2012

Research

Topical antimicrobial agents for burn wounds.

Clinics in plastic surgery, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.